Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. Germany
  4. Xetra
  5. Biofrontera AG
  6. News
  7. Summary
    B8F   DE0006046113

BIOFRONTERA AG

(B8F)
  Report
Delayed Xetra  -  11:36 2022-09-30 am EDT
1.465 EUR   +2.45%
09/06Biofrontera Obtains Notice of Allowance for US Patent Related to Nanoemulsion Technology
MT
08/25Biofrontera AG Appoints Prof. Dr. Karin Lergenmüller to the Supervisory Board
CI
08/19Biofrontera AG Announces Appointment of Pilar de la Huerta Martinez as New Chief Financial Officer
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Biofrontera AG Appoints Paul B÷ckmann to Management Board

06/09/2022 | 12:10pm EDT

The Supervisory Board of Biofrontera AG appointed Paul Böckmann to the company's Executive Board, initially for a limited time until August 31, 2022. Mr. Böckmann will support the current sole member of the Executive Board, Ludwig Lutter, as interims manager. Paul Böckmann is an independent management consultant and coach specializing in particular in global commercialization strategies, international business expansion and complex international reorganizations.

He has worked for various pharmaceutical companies, including CSL Behring AG and Sanochemia, and has specialized in the international commercialization of plasma derivatives since 2016. Since 2021, he has been advising internationally operating plasma companies on product commercialization and reorganization of their business activities with his own consulting company. In particular, he is to be involved in the above-mentioned dialogues between Biofrontera AG and Biofrontera Inc. to develop appropriate solutions for this process.


ę S&P Capital IQ 2022
All news about BIOFRONTERA AG
09/06Biofrontera Obtains Notice of Allowance for US Patent Related to Nanoemulsion Technolog..
MT
08/25Biofrontera AG Appoints Prof. Dr. Karin Lergenmüller to the Supervisory Board
CI
08/19Biofrontera AG Announces Appointment of Pilar de la Huerta Martinez as New Chief Financ..
CI
08/19Pta-news : Biofrontera AG: Biofrontera extends appointment of Management Board member Paul..
PU
08/19Biofrontera AG Extends Appointment of Management Board Member Paul Böckmann
CI
08/18Pta-news : Biofrontera AG: Biofrontera reports financial results for the six months ended ..
PU
08/18Biofrontera AG Provides Earnings Guidance for the Full Year of 2022
CI
08/17Pta-dd : Biofrontera AG: Managers' transactions announcement according to article 19 MAR
PU
08/12Earnings Flash (BFRI) BIOFRONTERA Posts Q2 Revenue $4.5M, vs. Street Est of $4.54M
MT
08/10Pta-news : Biofrontera AG: The request to convene an extraordinary shareholders' meeting b..
PU
More news
Financials
Sales 2022 26,2 M 25,7 M 25,7 M
Net income 2022 -38,1 M -37,4 M -37,4 M
Net Debt 2022 - - -
P/E ratio 2022 -2,44x
Yield 2022 -
Capitalization 83,1 M 81,5 M 81,5 M
Capi. / Sales 2022 3,17x
Capi. / Sales 2023 2,72x
Nbr of Employees 98
Free-Float 43,4%
Chart BIOFRONTERA AG
Duration : Period :
Biofrontera AG Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BIOFRONTERA AG
Short TermMid-TermLong Term
TrendsBullishBullishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 1
Last Close Price 1,47 €
Average target price 2,80 €
Spread / Average Target 91,1%
EPS Revisions
Managers and Directors
Maria del Pilar de la Huerta Martinez Chief Financial Officer
Wilhelm Konrad Zours Chairman-Supervisory Board
Heikki Lanckriet Member-Supervisory Board
Helge Lubenow Member-Supervisory Board
Karlheinz Schmelig Member-Supervisory Board
Sector and Competitors
1st jan.Capi. (M$)
BIOFRONTERA AG-1.01%81
CSL LIMITED-1.96%88 546
SAMSUNG BIOLOGICS CO.,LTD.-10.63%39 998
BIOGEN INC.11.29%38 745
WUXI BIOLOGICS (CAYMAN) INC.-48.78%25 758
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.-30.63%19 438